2019
DOI: 10.1016/j.dld.2019.03.033
|View full text |Cite
|
Sign up to set email alerts
|

Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group

Abstract: Hepatitis C virus (HCV) remains a significant public health problem and is one of the major causes of chronic liver disease worldwide. In recent years many new tools to facilitate widespread HCV screening and new therapeutic options with excellent efficacy and tolerability profiles and cost lowering policies have become available. To fully utilise these new tools, the link between local and specialist centres for the management of HCV infection must be reinforced. In order to GAIN further insight into these as… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 55 publications
0
8
0
Order By: Relevance
“…Other studies have shown that the lack of knowledge and a low level of awareness are also big barriers to HCV screening ( 19 , 20 ), and the early diagnosis can be the keystone in virus management ( 21 ). A group of experts interviewed to discuss relevant aspects and open issues of chronic hepatitis C in Italy and concluded that one of the main barriers to HCV care is the low screening rate ( 22 ).…”
Section: Introductionmentioning
confidence: 99%
“…Other studies have shown that the lack of knowledge and a low level of awareness are also big barriers to HCV screening ( 19 , 20 ), and the early diagnosis can be the keystone in virus management ( 21 ). A group of experts interviewed to discuss relevant aspects and open issues of chronic hepatitis C in Italy and concluded that one of the main barriers to HCV care is the low screening rate ( 22 ).…”
Section: Introductionmentioning
confidence: 99%
“…The first result of our study was that most Italian patients aged from 38 to 67 years, with a wide age range genotyperelated; the youngest were patients with genotype 3 infection (median age 50 years in male and female), and the older were females bearing genotype 2 (median age 72 years). Patients' ages have been analyzed with different approaches in previous Italian studies; 74.1% of individuals with more frequent HCV genotypes/subtypes were older than 41 years in the study by De Conto et al [28], 76.6% of patients aged from 35 to 74 years in the work of Stasi et al [30], who enrolled subjects referring to hepatology units in Tuscany from January 1 st , 2015, to December 31 st , 2015; Buonomo et al [31] found that 54.8% of known HCV+ Naples' patients who visited between January 2016 and March 2017 were >60 years old and the HCV Network Sicily [32] reported that the mean age of subjects registered on the web platform was 61 years and 34% of the subjects were >70 years. Taken together, the data seem to describe an HCV infected population aged similarly to ours: class age 58-67 years is less represented and class age 68-77 years more represented (16% vs. 11.9%) in Italian patients tested the year after the application of wider access criteria to HCV treatment with respect to those tested the year before (15.8% vs. 19.8%, respectively).…”
Section: Discussionmentioning
confidence: 99%
“…30 Alternatively, pragmatic approaches to screening strategies, such as random selection or using a hub-and-spoke model as trialed in Italy, can provide a practical compromise between universal and targeted screening. 31 Regardless of the model employed and populations targeted, screening to identify undiagnosed cases is vital in achieving elimination targets.…”
Section: Screening Programsmentioning
confidence: 99%